Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects the motor system. It is characterized by bradykinesia, resting tremor, rigidity, and postural instability. This article aims to provide healthcare professionals with a comprehensive overview of PD, including its pathophysiology, diagnosis, and management.
PD is primarily associated with the degeneration of dopaminergic neurons in the substantia nigra pars compacta. This leads to a significant reduction in striatal dopamine levels, disrupting the balance between the direct and indirect pathways of the basal ganglia, and resulting in the characteristic motor symptoms of PD. The exact cause of this neuronal degeneration remains unknown, but a combination of genetic and environmental factors is believed to contribute.
PD is primarily a clinical diagnosis based on the presence of characteristic motor symptoms. Neuroimaging techniques, such as DaTscan, can be used to support the diagnosis, but are not necessary in typical cases. Early diagnosis of PD can be challenging due to the subtle and nonspecific nature of early symptoms, emphasizing the need for a high degree of clinical suspicion.
Management of PD is primarily symptomatic, with levodopa being the most effective medication for motor symptoms. However, its long-term use can lead to motor complications, such as dyskinesias and motor fluctuations. Therefore, the timing of levodopa initiation and the choice of other dopaminergic medications must be individualized. Non-pharmacological interventions, including physiotherapy and occupational therapy, also play a crucial role in managing the disease.
PD is a complex neurodegenerative disorder that requires a comprehensive and individualized approach to diagnosis and management. Understanding the pathophysiology, recognizing the early signs, and being aware of the various therapeutic options are crucial for healthcare professionals in providing optimal care to patients with PD.
1.
Regular physical activity before cancer diagnosis may lower progression and death risks
2.
Medication Self-Injection Embraced by Breast Cancer Patients
3.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
4.
FDA Advisors Split on Regimens for Breast, Prostate Cancers
5.
ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs
1.
RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health
2.
Clinical Pathways in Hematology in Clinical Decision-Making
3.
Immune Surveillance Screening for Early Cancer Risk Detection
4.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
5.
AI-Driven Digital Pathology in Oncology: From Histology Images to Predictive Treatment Biomarkers
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
How Advances in Cancer Research Are Improving Treatment Options
2.
Navigating the Complexities of Ph Negative ALL - Part II
3.
Signs and Symptoms of Leukemia
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation